SEC Form 4 · accession 0001179110-18-008295
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Brannon Johnston
Officer — Chief Financial Officer
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2018 | M | 10,000 | $3.05 | A | 190,690 | D | |
| Common StockF2 | Jun 6, 2018 | S | 10,000 | $11.02 | D | 180,690 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F3 | $3.05 | Jun 6, 2018 | M | 10,000 | D | Jul 18, 2017 | Jul 18, 2026 | Common stock | 10,000 | 90,000 | D |
Explanation of responses
- F1The transaction reported in this Form 4 was made pursuant to a 10(b)5-1 trading plan executed by the reporting person on March 7, 2018.
- F2Weighted average price of shares sold
- F3Exercisable in three equal installments over three years starting on the first year anniversary of the grant.